Bleeding patterns in women using intramuscular progesterone for luteal support in in-vitro fertilisation cycles

Journal of Obstetrics and Gynaecology

Volumn 23, Issue 3, 2003, Pages 267-270

  Gürbüz, Birgül ^a,b   Yalti, S ^a   Ficicioglu C ^a   Delikara, N ^a   Alpay, Z ^a  

^a Zeynep Kamil Women/Children Educ/R   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; LEUPRORELIN; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; EMBRYO TRANSFER; ENDOMETRIUM; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; HUMAN; LUTEAL PHASE; MAJOR CLINICAL STUDY; OOCYTE TRANSPORT; PREGNANCY RATE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; UTERINE BLEEDING PATTERN;

ADULT; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; EMBRYO TRANSFER; ENDOMETRIUM; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; HUMANS; INJECTIONS, INTRAMUSCULAR; LUTEAL PHASE; MENSTRUATION; PROGESTERONE; RETROSPECTIVE STUDIES;

EID: 0038377717     PISSN: 01443615     EISSN: None     Source Type: Journal    
DOI: 10.1080/01443610310000100079     Document Type: Article

References (19)

1. Araujo E. Jr, Bernardini L., Frederick J.L., Asch R.H. and Balmaceda J.P. (1994) Prospective randomized comparison of human chrionic gonadotrophin versus intramuscular progesterone for luteal phase support in assisted reproduction. Journal of Assisted Reproduction and Genetics, 11, 74-78.
2. Artini P.G., Volpe A., Angioni S., Galassi M.C., Battaglia C. and Genazzani A.R. (1995) A comparative, randomized study of three different progesterone support of the luteal phase following IVF/ET program. Journal of Endocrinological Investigation, 18, 51-56.
3. Bourgain C., Devroey P., Van Waesberghe L., Smitz J. and Van Steirteghem A.C. (1990) Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure. Human Reproduction, 5, 537-543.
4. Csapo A.L., Pulkkinen M.O., Ruttner B., Sauvage J.P. and Wlest W.G. (1972) The significance of human corpus luteum in pregnancy maintenance. American Journal of Obstetrics and Gynecology, 112, 1061-1063.
5. Devroey P., Palermo G., Bourgain C., Van Waesberghe L., Smitz J. and Van Steirteghem A.C. (1989) Progesterone administration in patients with absent ovaries. International Journal of Fertility, 34, 188-193.
6. Ginsburg K.A. (1992) Luteal phase defect. Etiology, diagnosis and management. Endocrinology and Metabolism Clinics of North America, 21, 85-104.
7. Johansson E.D.B. (1972) Plasma levels of progesterone achieved by different routes of administration. Acta Obstetricia et Gynecologica Scandinavica, 19 (Supplement), 17-20.
8. Jones G.S. (1991) Luteal phase defect: a review of pathophysiology. Current Opinion in Obstetrics and Gynecology, 3, 641-648.
9. Jordan J., Craig K., Clifton D.K. and Soules M.R. (1994) Luteal phase defect: the sensitivity and specificity of diagnostic methods in common clinical use. Fertility and Sterility, 62, 54-62.
10. Miles R.A., Paulson R.J., Lobo R.A., Press M.F., Dahmoush L. and Sauer M.V. (1994) Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study. Fertility and Sterility, 62, 485-490.
11. Nillius S.J. and Johansson E.D.B. (1971) Plasma levels of progesterone after vaginal, rectal or intramuscular administration of progesterone. American Journal of Obstetrics and Gynecology, 110, 470-477.
12. Roman E., Aytoz A., Smitz J.E.J., Faguer B., Camus M., Van Steirteghem A.C. and Devroey P. (2000) Analysis of the bleeding pattern in assisted reproduction cycles with luteal phase supplementation using vaginal micronized progesterone. Human Reproduction, 7, 1435-1439.
13. Simon J., Robinson D., Andrews M., Hildebrand J.R., Rocci M.L., Blake R.E. and Hodgen G.D. (1993) The absorption of oral micronized progesterone: the effects of food, dose proportionality and comparison with intramuscular progesterone. Fertility and Sterility, 60, 26-33.
14. Soliman S., Daya S., Collins J. and Hughes E.G. (1994) The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials. Fertility and Sterility, 61, 1068-1076.
15. Smitz J., Devroey P., Camus M., Deschacht J., Khan I., Staessen O., Von Waesberghe L., Wisanto A. and Van Steirteghem A.C. (1985) The luteal phase and early pregnancy after combined GnRH-agonist-HMG treatment for superovulation in IVF or GIFT. Human Reproduction, 3, 585-590.
16. Smitz J., Devroey P., Faguer B., Bourgain C., Camus M., Van Steirteghem A.C. (1992) A prospective randomized comparison of intramuscular or intravaginal natural progesterone as a luteal phase and early pregnancy supplement. Human Reproduction, 7, 168-175.
17. Steege J., Rupp S., Stout A., and Bernhisel M. (1986) Bioavailability of nasally administered progesterone. Fertility and Sterility, 46, 727-729.
18. Stovall D., Van Voorhis B., Mattingly K., Sparks A.E., Chapler F.K. and Syrop C.H. (1996) The effectiveness of sublingual progesterone administration during cryopreserved embryo transfer cycles: results of a matched follow-up study. Fertility and Sterility, 65, 986-991.
19. Villanueva B., Casper R.F. and Yen S.S.C. (1981) Intravaginal administration of progesterone: enhanced absorption after estrogen treatment. Fertility and Sterility, 35, 433-437.